Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Total 13F shares
-
31,175,535
-
Share change
-
+6,125,855
-
Total reported value
-
$451,621,332
-
Price per share
-
$14.49
-
Number of holders
-
94
-
Value change
-
+$89,759,637
-
Number of buys
-
76
-
Number of sells
-
22
Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q4 2021
As of 31 Dec 2021,
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,175,535 shares.
The largest 10 holders included
Essex Woodlands Management, Inc., Juniper Investment Company, LLC, BlackRock Inc., ROYCE & ASSOCIATES LP, SV Health Investors, LLC, VANGUARD GROUP INC, Redmile Group, LLC, NUANCE INVESTMENTS, LLC, Tamarack Advisers, LP, and PURA VIDA INVESTMENTS, LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.